SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Art Pappas is on the steering committeee of the "Partnering for Global Health Forum 2008" in Washington, DC
News | 03. 10. 2008